Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free IMCC Stock Alerts

IM Cannabis (IMCC) Financials

IM Cannabis logo
$1.96 -0.02 (-1.01%)
Closing price 09/8/2026 04:00 PM Eastern
Extended Trading
$2.00 +0.04 (+1.99%)
As of 09/8/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for IM Cannabis

Annual Income Statements for IM Cannabis

This table shows IM Cannabis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -25 -16 -13 -282 -15 -17 -19
Consolidated Net Income / (Loss)		 -5.72 -23 -14 -141 -7.75 -8.17 -8.57
Net Income / (Loss) Continuing Operations		 -25 -23 -13 -18 0.00 0.00 0.00
Total Pre-Tax Income 		-5.65 -16 -13 -19 -7.16 -8.88 -8.50
Total Operating Income		 -18 -6.46 -13 -23 -9.69 -7.11 -8.45
Total Gross Profit		 3.03 8.21 4.96 6.77 7.46 5.87 7.06
Total Revenue		 9.81 13 0.00 40 37 38 40
Operating Revenue		 9.81 13 - 40 37 38 40
Total Cost of Revenue		 15 24 0.00 32 29 34 38
Operating Cost of Revenue		 15 24 - 32 29 34 38
Total Operating Expenses		 13 4.08 13 26 17 11 11
Selling, General & Admin Expense		 7.01 9.05 13 18 8.51 5.82 6.95
Marketing Expense		 0.96 2.96 - 8.48 8.17 4.91 3.91
Total Other Income / (Expense), net		 -6.47 0.00 0.00 3.50 2.53 -1.78 -0.05
Interest Expense		 - - - 1.46 2.78 3.31 2.55
Interest & Investment Income		 - - - 4.95 5.31 1.54 2.50
Income Tax Expense		 0.07 0.21 - -0.84 0.58 -0.71 0.07
Net Income / (Loss) Discontinued Operations		 - 0.00 - -123 0.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.16 - - 1.78 0.55 0.82 0.31
Basic Earnings per Share		 ($0.18) - - ($130.54) ($3.37) ($3.13) ($1.95)
Weighted Average Basic Shares Outstanding		 - 159.06M 68.22M 7.57M 13.39M 3.09M 5.89M
Diluted Earnings per Share		 ($0.18) ($3.80) - ($136.52) ($3.37) ($3.13) ($1.95)
Weighted Average Diluted Shares Outstanding		 - 159.06M 68.22M 7.57M 13.39M 3.09M 5.89M
Weighted Average Basic & Diluted Shares Outstanding		 - 159.06M 68.22M 7.57M 13.39M 3.09M 5.89M

Quarterly Income Statements for IM Cannabis

No quarterly income statements for IM Cannabis are available.

Annual Cash Flow Statements for IM Cannabis

This table details how cash moves in and out of IM Cannabis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 4.88 -24 3.93 -30 -12 -8.31 0.68
Net Cash From Operating Activities		 -0.22 -24 -27 -34 -13 -5.35 2.15
Net Cash From Continuing Operating Activities		 -0.22 -24 -18 -34 -13 -5.35 2.15
Net Income / (Loss) Continuing Operations		 -6.26 -23 -14 -146 -10 -9.51 -8.92
Consolidated Net Income / (Loss)		 -6.26 -23 -14 -146 -10 -9.51 -8.92
Depreciation Expense		 0.37 0.54 3.58 3.69 0.94 0.56 0.45
Amortization Expense		 0.10 0.02 - 1.73 1.33 0.96 0.98
Non-Cash Adjustments To Reconcile Net Income		 9.73 -2.06 1.62 97 -1.34 1.72 5.51
Changes in Operating Assets and Liabilities, net		 -0.00 -0.05 -9.10 11 -4.00 0.93 4.14
Net Cash From Investing Activities		 -1.19 0.00 -7.05 6.12 3.71 1.94 2.38
Net Cash From Continuing Investing Activities		 -1.19 0.00 -7.07 6.12 3.71 1.94 2.38
Purchase of Property, Plant & Equipment		 0.00 - -3.60 -1.15 -0.44 -0.11 -0.01
Sale of Property, Plant & Equipment		 1.19 0.00 0.00 7.28 4.15 2.05 2.39
Net Cash From Financing Activities		 11 0.00 38 -0.66 -2.38 -2.66 -1.32
Net Cash From Continuing Financing Activities		 11 0.00 27 -0.66 -2.38 -2.66 -1.32
Repayment of Debt		 0.00 0.00 -1.55 -3.68 -3.66 -2.66 -1.32
Issuance of Common Equity		 - - 22 0.25 - 0.00 0.00
Effect of Exchange Rate Changes		 -0.76 - - -1.51 -0.60 -2.24 -2.53
Cash Interest Paid		 - - - 0.67 1.26 1.44 1.84

Quarterly Cash Flow Statements for IM Cannabis

No quarterly cash flow statements for IM Cannabis are available.

Annual Balance Sheets for IM Cannabis

This table presents IM Cannabis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 24 30 225 45 37 27 23
Total Current Assets		 19 21 60 24 13 16 17
Cash & Equivalents		 11 6.97 11 1.81 - 0.60 1.99
Restricted Cash		 - - - - - 0.04 0.42
Short-Term Investments		 - 0.00 0.00 - - 1.13 1.30
Accounts Receivable		 1.79 4.85 24 8.87 5.80 9.59 7.91
Inventories, net		 6.16 9.38 25 13 7.56 2.23 3.11
Other Current Assets		 - - - - - 3.76 3.15
Plant, Property, & Equipment, net		 2.61 4.34 24 3.86 3.83 2.59 2.71
Plant, Property & Equipment, gross		 - - - - - 2.59 2.71
Total Noncurrent Assets		 2.51 4.34 141 17 19 7.27 2.56
Goodwill		 0.23 0.24 95 7.22 7.65 4.64 1.37
Intangible Assets		 0.69 0.86 24 5.85 4.40 2.31 0.89
Other Noncurrent Operating Assets		 0.83 0.81 18 1.43 5.72 0.31 0.29
Total Liabilities & Shareholders' Equity		 24 30 225 45 37 27 23
Total Liabilities		 3.69 20 65 27 27 25 26
Total Current Liabilities		 2.01 4.91 33 18 6.99 24 25
Short-Term Debt		 - - - - - 11 10
Accounts Payable		 1.89 4.78 27 16 6.99 7.75 8.79
Other Current Liabilities		 0.12 0.13 1.22 0.60 0.00 4.62 5.10
Total Noncurrent Liabilities		 1.68 15 32 9.09 19 0.78 0.98
Long-Term Debt		 - 0.00 7.74 7.13 9.18 1.69 1.14
Capital Lease Obligations		 0.69 0.65 14 0.79 - 0.12 0.04
Noncurrent Deferred & Payable Income Tax Liabilities		 0.64 1.18 5.16 0.98 0.73 0.34 0.26
Total Equity & Noncontrolling Interests		 20 9.89 160 18 10 2.18 -2.64
Total Preferred & Common Equity		 19 8.70 157 17 11 3.64 -2.72
Total Common Equity		 19 8.70 157 17 11 3.64 -0.65
Common Stock		 20 29 186 182 192 184 197
Retained Earnings		 -3.29 -26 -40 -177 -189 -180 -197
Other Equity Adjustments		 2.30 5.53 12 12 7.37 -0.57 -0.87
Noncontrolling Interest		 1.12 1.19 2.90 0.85 -0.58 -1.46 0.08

Quarterly Balance Sheets for IM Cannabis

No quarterly balance sheets for IM Cannabis are available.

Annual Metrics And Ratios for IM Cannabis

This table displays calculated financial ratios and metrics derived from IM Cannabis' official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 159,063,128.00 68,217,894.00 7,569,526.00 13,394,136.00 3,085,452.00 5,894,812.00
DEI Adjusted Shares Outstanding		 0.00 2,651,052.00 1,136,965.00 1,261,588.00 2,232,356.00 3,085,452.00 5,894,812.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -5.99 -11.85 -223.54 -6.91 -5.35 -3.16
Growth Metrics		 - - - - - - -
Profitability Metrics		 - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -13 -4.52 -9.43 -16 -6.78 -4.97 -5.92
Return On Investment Capital (ROIC_SIMPLE)		 - - - -62.44% -34.68% -34.28% -65.78%
Earnings before Interest and Taxes (EBIT)		 -25 -6.46 -13 -23 -9.69 -7.11 -8.45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -24 -5.90 -9.90 -17 -7.42 -5.59 -7.02
Valuation Ratios		 - - - - - - -
Leverage & Solvency		 - - - - - - -
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 3.12 -177 131 -2.69 0.12 1.54
Efficiency Ratios		 - - - - - - -
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 9.37 1.73 169 22 18 13 5.28
Increase / (Decrease) in Invested Capital		 0.00 -7.64 168 -147 -4.09 -5.09 -7.45
Book Value per Share		 $0.00 $0.05 $0.99 $0.25 $1.45 $1.18 ($0.21)
Tangible Book Value per Share		 $0.00 $0.05 $0.24 $0.05 ($0.14) ($1.07) ($0.95)
Total Capital		 21 11 182 26 20 15 8.99
Total Debt		 0.69 0.65 22 7.92 9.18 12 12
Total Long-Term Debt		 0.69 0.65 22 7.92 9.18 1.81 1.18
Net Debt		 -11 -8.15 8.91 4.33 7.45 11 7.92
Capital Expenditures (CapEx)		 -1.19 0.00 3.60 -6.12 -3.71 -1.94 -2.38
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 5.94 9.32 17 4.18 6.37 0.72 -1.47
Debt-free Net Working Capital (DFNWC)		 17 16 27 5.99 6.37 2.49 2.24
Net Working Capital (NWC)		 17 16 27 5.99 6.37 -8.02 -8.22
Net Nonoperating Expense (NNE)		 -7.01 18 5.06 125 0.96 3.20 2.65
Net Nonoperating Obligations (NNO)		 -11 -8.15 8.91 4.33 7.45 11 7.92
Total Depreciation and Amortization (D&A)		 0.46 0.57 3.58 5.42 2.27 1.52 1.43
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($34.81) $0.00 $0.00 $0.00 ($6.26) ($1.95)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 2.65M 1.14M 1.26M 2.23M 3.09M 5.89M
Adjusted Diluted Earnings per Share		 $0.00 ($34.81) ($39.60) ($323.76) ($8.88) ($6.26) ($1.95)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 2.65M 1.14M 1.26M 2.23M 3.09M 5.89M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($34.81) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 2.65M 1.14M 1.26M 2.23M 3.09M 5.89M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -4.52 -9.43 -16 -6.78 -4.97 -5.92
Debt Service Ratios		 - - - - - - -
Payout Ratios		 - - - - - - -

Quarterly Metrics And Ratios for IM Cannabis

No quarterly metrics and ratios for IM Cannabis are available.


Financials Breakdown Chart

IM Cannabis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IM Cannabis' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

IM Cannabis' net income appears to be on a downward trend, with a most recent value of -$8.57 million in 2025, rising from -$5.72 million in 2019. The previous period was -$8.17 million in 2024. Find out what analysts predict for IM Cannabis in the coming months.

IM Cannabis' total operating income in 2025 was -$8.45 million, based on the following breakdown:
  • Total Gross Profit: $7.06 million
  • Total Operating Expenses: $10.86 million

Over the last 6 years, IM Cannabis' total revenue changed from $9.81 million in 2019 to $39.91 million in 2025, a change of 306.9%.

IM Cannabis' total liabilities were at $25.78 million at the end of 2025, a 3.0% increase from 2024, and a 599.1% increase since 2019.

In the past 6 years, IM Cannabis' cash and equivalents has ranged from $0.00 in 2023 to $10.88 million in 2021, and is currently $1.99 million as of their latest financial filing in 2025.

Over the last 6 years, IM Cannabis' book value per share changed from 0.00 in 2019 to -0.21 in 2025, a change of -21.1%.


Related Companies

Financial statements for NASDAQ:IMCC last updated on 8/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel